首页期刊导航|国际中医中药杂志
期刊信息/Journal information
国际中医中药杂志
中国中医研究院中医药信息研究所
国际中医中药杂志

中国中医研究院中医药信息研究所

曹洪欣

月刊

1673-4246

guowaiyixue@yahoo.com.cn

010-64014411-3225

100700

北京市东直门内南小街16号中国中医科学院中医药信息研究所

国际中医中药杂志/Journal International Journal of Traditional Chinese Medicine北大核心CSTPCD
查看更多>>中华人民共和国卫生部主管，中华医学会、中国中医科学院中医药信息研究所主办。本刊以反映国内外中医药学研究的最新进展，促进国内外中医药学的学术交流为己任，以中医药科研、临床、生产、管理工作者为主要对象，介绍中医药学领域有关的新进展、新技术和新方法。开设了专题论坛、特别报道、临床研究、实验研究、临床调研、思路与方法、研究动态、信息研究、临床报道、临证心得、综述等栏目。为中国科技论文统计源期刊（中国科技核心期刊）。
正式出版
收录年代

    基于分子对接技术探讨甘草次酸对咳嗽变异性哮喘小鼠免疫系统Th2偏移的影响

    陈秋玲刘华宇周艾玲李燕玲...
    191-195页
    查看更多>>摘要：目的 基于分子对接技术探讨甘草次酸对咳嗽变异性哮喘小鼠Th2偏移的纠正作用，探讨其治疗咳嗽变异性哮喘的可能性。 方法 利用Autodock Vina软件进行分子对接。将小鼠按随机数字表法分为空白对照组、模型组、醋酸泼尼松组及甘草次酸高、中、低剂量组，每组8只。除空白对照组外，其余各组采用卵蛋白诱导的方法建立咳嗽变异性哮喘模型。甘草次酸高、中、低剂量组灌胃甘草次酸混悬液20、10、5 mg/kg，醋酸泼尼松组灌胃醋酸泼尼松5 mg/kg，空白对照组和模型组灌胃等体积的生理盐水。1次/d，连续14 d。观察各组小鼠行为；采用阿利新蓝-过碘酸希夫染色观察肺组织支气管黏液分泌情况；计算小鼠脾脏指数；采用Western blot法检测脾组织中Gata结合蛋白3（Gata3）、IL-4、IL-13蛋白表达。 结果 分子对接结果表明，甘草次酸与Th2相关因子Gata3、IL-4和IL-13有较好的结合活性。动物实验结果表明，与模型组比较，甘草次酸各剂量组小鼠肺组织黏液分泌减少，甘草次酸低剂量组脾脏指数降低，甘草次酸高、中、低剂量组IL-4、IL-13表达降低（P<0.05），甘草次酸中、低剂量组Gata3表达降低（P<0.05）。 结论 甘草次酸可纠正咳嗽变异性哮喘小鼠免疫系统Th2的偏移，具有一定的治疗作用。 Objective To evaluate the therapeutic effect of glycyrrhetinic acid on cough variant asthma (CVA) mice based on molecular docking technique To explore the possibility of its treatment for cough variant asthma. Methods The software of Autodock Vina was used for molecular docking. The mice were divided into control group, model group, prednisone acetate group, glycyrrhetinic acid high-, medium-, and low-dosage groups according to the random number table method, with 8 mice in each group. Except for the blank control group, all other groups were induced by egg protein to establish cough variant asthma models. Glycyrrhetinic acid high-, medium-, and low-dosage groups were orally administered glycyrrhetinic acid suspension at 20, 10, and 5 mg/kg, while the prednisone acetate group was orally administered prednisone acetate at 5 mg/kg. The blank control group and model group were orally administered equal volumes of physiological saline, once per day for 14 consecutive days. The animal asthma behavior was observed after drug administration. The secretion of bronchial mucus in lung tissue were observed by AB-PAS staining and the index of spleen were recorded. The protein expressions of Gata3, IL-4 and IL-13 in the spleen tissue were determined by Western blot. Results Molecular docking results showed that glycyrrhetinic acid had good binding ability to Th2-related factors Gata3, IL-4 and IL-13. Results of animal experiment showed that compared with the model group, the mucus secretion decreased in glycyrrhetinic acid groups, the index of the spleen of mice obviously decreased, protein expression levels of IL-4 and IL-13 in the spleen tissue of mice in glycyrrhetinic acid high-, medium-, and low-dosage groups decreased (P<0.05), and Gata3 in glycyrrhetinic acid medium- and low-dosage groups decreased (P<0.05). Conclusion Glycyrrhetinic acid can correct the shift of Th2 in the immune system of cough variant asthma mice and has a certain therapeutic effect.

    甘草次酸咳嗽变异性哮喘Th2细胞分子对接

      原文链接:
    • 万方数据

    基于网络药理学研究黄龙合剂治疗小儿咳嗽变异性哮喘的机制及实验验证

    纪茜茜王爱华隆红艳张琪...
    196-202页
    查看更多>>摘要：目的 利用网络药理学方法、分子对接技术及体外细胞实验研究黄龙合剂基于IL-4/信号转导和转录激活因子6（STAT6）信号通路治疗小儿咳嗽变异性哮喘（CVA）的作用机制。 方法 通过TCMSP、HERB数据库及文献检索获得黄龙合剂组方中药的活性成分及作用靶点，检索GeneCards数据库、OMIM数据库、DrugBank数据库、PharmGKB数据库中CVA相关靶点。对药物-疾病靶点取交集，使用STRING数据库构建交集靶点PPI网络，采用Cytoscape 3.9.1进行网络拓扑分析，筛选核心靶点，并构建“疾病-药物-成分-靶点”网络，筛选核心成分。使用Metascape数据库对交集靶点进行GO功能和KEGG通路富集分析。使用PDB蛋白数据库、PubChem、AutoDock及R语言对核心靶点及核心成分进行分子对接验证。培养大鼠原代气道平滑肌细胞，采用Western blot检测细胞质和细胞核中p-STAT6表达。 结果 得到黄龙合剂治疗CVA的活性成分122个，核心成分包括槲皮素、山柰酚、木犀草素等，核心靶点有JUN、ESR1、TP53、MYC、HIF1α等。GO功能富集分析涉及对外来刺激的反应、对氧气水平的反应、蛋白质磷酸化的正向调控、细胞应激反应的调节等生物过程。KEGG通路富集分析显示，黄龙合剂治疗CVA靶点主要富集于AGE-RAGE信号通路、PI3K-Akt信号通路、TNF信号通路、JAK-STAT信号通路等。分子对接结果显示，核心靶点及药物核心成分有较好的结合活性。细胞实验表明，黄龙合剂可抑制IL-4介导的p-STAT6进入细胞核。 结论 预测了黄龙合剂治疗CVA的有效成分及靶点，其治疗小儿CVA的作用机制可能与抑制IL-4/STAT6信号通路有关。 Objective To study the the mechanism of action of Huanglong Mixture in the treatment of cough variant asthma (CVA) in children based on the IL-4/signal transduction and activator of transcription 6 (STAT6) signaling pathway using network pharmacology methods, molecular docking techniques, and in vitro cell experiments. Methods The components and targets of various TCM components in Huanglong Mixture were searched in TCMSP database, HERB database and literature, and the disease targets of CVA were found in Gene Cards database, OMIM database, DrugBank database and PharmGkb database. The STRING database was used to construct the protein-protein interaction network, and Cytoscape 3.9.1 was used for topology analysis to screen out the core targets. The disease-drug-component-target network was constructed to screen out the core components. The KEGG enrichment analysis and GO enrichment analysis of the intersection targets were performed using Metascape software. PDB protein database, PubChem, Autodock and R language were used for molecular docking verification of core targets and core drug components. Finally, rat primary airway smooth muscle cells were cultured, modeled with interleukin-4 (IL-4), and p-STAT6 expression in the cytoplasm and nucleus was detected by Western blot. Results A total of 122 effective components were obtained, including quercetin, kaempferol, luteolin and so on. The core targets included JUN, ESR1, TP53, MYC, HIF1, etc. GO enrichment analysis involved biological processes such as response to external stimuli, response to oxygen levels, positive regulation of protein phosphorylation, and regulation of cellular stress response. KEGG enrichment analysis showed that the main pathways of Huanglong Mixture in treating CVA included advanced glycation end product-glycation end product receptor (AGE-RAGE) signaling pathway, phosphatidylinositol-3-kinase-protein kinase B (PI3K-Akt) signaling pathway, tumor necrosis factor (TNF) signaling pathway, Janus kinase/signal transduction activation factor (JAK-STAT) signaling pathway. Molecular docking found that the core targets and core drug components had good combination. Cell experiments also confirmed that Huanglong Mixture could inhibit p-STAT6 entering the nucleus. Conclusions The effective components and targets of Huanglong Mixture in the treatment of CVA are successfully predicted. The mechanism of Huanglong Mixture in the treatment of children with CVA may be related to the inhibition of IL-4/STAT6 signaling pathway.

    药理作用分子作用机制（中药）咳嗽变异性哮喘黄龙合剂网络药理学分子对接模拟IL-4/STAT6信号通路

      原文链接:
    • 万方数据

    基于网络药理学探讨化瘀丸辅助免疫检查点抑制剂治疗三阴性乳腺癌作用机制

    杨雯靖杨国旺张琪
    203-208页
    查看更多>>摘要：目的 运用网络药理学方法探讨化瘀丸辅助免疫检查点抑制剂治疗三阴性乳腺癌（TNBC）的潜在作用机制。 方法 利用TCMSP、PubChem、STITCH和SwissTargetPrediction数据库分析化瘀丸潜在作用靶点。基于癌症和肿瘤基因图谱（TCGA）数据库筛选TNBC疾病靶点。将药物-疾病映射靶点进行PPI网络构建、关键靶点筛选和模块分析，并运用DAVID数据库进行GO功能注释和KEGG信号通路富集分析。大鼠灌胃化瘀丸水煎液3.94 g/kg，连续给药4 d，制备含药血清。将人脐静脉血管内皮细胞（HUVEC）按随机数字表法分为对照组和实验组，实验组给予化瘀丸含药血清干预24 h后，接种于Matrigel已凝固的48孔板中，3 h后观察HUVEC血管形成情况。 结果 获得化瘀丸治疗TNBC的可能作用靶点130个，VEGFA为核心作用靶点，血管生成、缺氧、凝血级联反应可能为化瘀丸治疗TNBC的主要相关功能及关键信号通路。体外研究表明，化瘀丸含药血清可促进HUVEC细胞肿瘤血管正常化。 结论 化瘀丸可能通过VEGF靶点促进肿瘤血管正常化（血管生成、缺氧、凝血级联反应），可辅助免疫检查点抑制剂发挥治疗TNBC的功效。 Objective To explore the potential mechanism of Huayu Pills in the treatment of TNBC (triple-negative breast cancer) using network pharmacology. Methods TCMSP (Traditional Chinese Medicine Systems Pharmacology), PubChem, STITCH and SwissTargetPrediction databases were used to analyze the potential targets of Huayu Pills. TNBC disease targets were screened based on the TCGA (The Cancer Genome Atlas) database. The drug-disease mapping target was constructed by PPI network, key target screening and module analysis, and the DAVID database was used for GO function annotation and KEGG signal pathway enrichment analysis. SD rats were orally administered 3.94 g/kg of Huayu Pills decoction for 4 days to prepare medicated serum. HUVEC cells were randomly divided into a control group and an experimental group using a random number table method. The experimental group received intervention with Huayu Pills containing serum for 24 hours, inoculated in matrigel's solidified 48 well plate and HUVEC angiogenesis was observed 3 hours later. Results 130 possible targets of Huayu Pills in the treatment of TNBC were obtained. VEGFA is the core target. The cascade of angiogenesis, hypoxia, and blood coagulation may be the main functions and key signals of Huayu Pills in the treatment of TNBC. In vitro studies have shown that serum containing Huayu Pills can promote the normalization of tumor blood vessels in HUVEC cells. Conclusion Huayu Pills may promote tumor vascular normalization (angiogenesis, hypoxia, coagulation cascade reactions) through VEGF targets, and can assist immune checkpoint inhibitors in the treatment of TNBC.

    三阴性乳腺肿瘤网络药理学化瘀丸药理作用分子作用机制（中药）

      原文链接:
    • 万方数据

    野生和不同栽培方式桑黄药材质量分析

    吴陈晨严露蒲婧哲张亚中...
    209-214页
    查看更多>>摘要：目的 通过对桑黄药材的超高效液相色谱（UPLC）特征图谱和多组分含量测定结果进行分析，比较并评价野生和不同栽培方式桑黄药材质量。 方法 采用UPLC建立桑黄药材的特征图谱及多组分含量测定方法，并运用聚类分析、正交偏最小二乘法-判别分析（OPLS-DA）方法进行化学模式识别分析。 结果 18批桑黄药材特征图谱有10个共有峰，指认出麦角硫因（峰1）、原儿茶酸（峰2）、原儿茶醛（峰3）、咖啡酸（峰4）、Hispidin（峰5）5个成分，聚类分析、OPLS-DA可将野生品及不同栽培方式桑黄药材明确区分。 结论 段木栽培桑黄较袋料栽培桑黄与野生桑黄更接近，建立的UPLC特征图谱和多成分含量测定方法可为桑黄药材的质量评价提供参考。 Objective To compare and evaluate the quality of wild and different cultivation methods of Sanghuang porus vaninii (Ljub.) L.W. Zhou & Y.C. Dai through analysis on UPLC characteristic atlas and multi-component content determination results. Methods UPLC was used to establish the characteristic chromatogram and multi-component content determination method of Sanghuang porus vaninii (Ljub.) L.W. Zhou & Y.C. Dai, and clustering analysis, orthogonal partial least squares - discriminant analysis method were used for chemical pattern recognition analysis. Results The results showed that there were 10 common peaks in 18 batches of Sanghuang porus vaninii (Ljub.) L.W. Zhou & Y.C. Dai. Five components were identified, erythrothioneine(peak 1), protocatechuic acid (peak 2), protocatechualdehyde (peak 3), caffeic acid (peak 4) and Hispidin (peak 5). HCA and OPLS-DA could distinguish Sanghuang porus vaninii (Ljub.) with different cultivation methods. Conclusion Sanghuang porus vaninii (Ljub.)L.W. Zhou & Y.C. Dai in wood is closer to wild Sanghuang porus vaninii (Ljub.) L.W. Zhou & Y.C. Dai than in substitute cultivation. The UPLC characteristic atlas and multi-component content determination method established in this study can provide reference for the quality evaluation of Sanghuang porus vaninii (Ljub.) L.W. Zhou & Y.C. Dai.

    质量控制超高效液相色谱桑黄药用植物栽培

      原文链接:
    • 万方数据

    基于UPLC指纹图谱和含量测定的不同产地密蒙花药材质量评价研究

    位翠杰刘晓霞段志文冯涌微...
    215-221页
    查看更多>>摘要：目的 建立密蒙花超高效液相色谱（UPLC）指纹图谱和2个有效成分含量测定方法，为全面评价不同产地密蒙花药材的质量提供参考。 方法 采用UPLC法建立密蒙花药材的指纹图谱；对其进行相似度评价、聚类分析、主成分分析和正交偏最小二乘法判别分析（OPLS-DA），并测定密蒙花药材中毛蕊花糖苷和蒙花苷含量。 结果 17批密蒙花药材指纹图谱有12个共有指纹峰，经对照品比对，指认其中6个指纹峰，分别为松果菊苷、蒙花苷、木犀草苷、毛蕊花糖苷、异类叶升麻苷、芹菜素；17批密蒙花药材指纹图谱相似度均大于0.9；不同产地的药材分为2类，采用OPLS-DA发现5个差异性标志物，显著性差异排序分别为毛蕊花糖苷>峰3>松果菊苷>异类叶升麻苷>蒙花苷；采用指纹图谱方法对伪品结香花药材进行有效鉴别；湖北和四川产区的密蒙花药材含量较高且稳定。 结论 该方法可有效分析不同产地密蒙花药材的质量差异，为其质量控制提供依据。 Objective To establish UPLC fingerprint method and 2 contents determination methods of Buddleja officinalis To provide a reference for improving the quality control standard and evaluation of Buddleja officinalis from different habitats. Methods UPLC method was used to establish the fingerprints of 17 batches of Buddleja officinalis. The similarity evaluation, clustering analysis, principal component analysis and orthogonal partial least squares discriminant analysis were used to compare the quality differences of Buddleja officinalis from different habitats. The contents of acteoside and linarin in Buddleja officinalis were determined. Results There were 12 common peaks in UPLC fingerprints of Buddleja officinalis, six of which were identified as echinacoside, acteoside, cynaroside, isoacteoside, linarin, and apigenin. The fingerprint similarity of 17 batches of Buddleja officinalis was more than 0.9 Buddleja officinalis from different habitats were classified into 2 groups. Five differential markers were determined by OPLS-DA analysis. The order of significance was acteoside > peak 3 > echinacoside > isoacteoside > linarin. Edgeworthia chrysantha was identified by the method of fingerprint as counterfeit. The results of content determination showed that the content of Buddleja officinalis in Hubei and Sichuan was the high and stable. Conclusion The method can effectively analyze the differences of Buddleja officinalis from different habitats, and provide reference for the quality control of Buddleja officinalis.

    密蒙花UPLC指纹图谱含量测定（中药）质量控制

      原文链接:
    • 万方数据

    治疗冠状动脉微循环障碍的潜在中药预测研究

    朱春临史大卓魏康康苗丽娜...
    222-228页
    查看更多>>摘要：目的 基于冠状动脉微循环障碍（CMD）的疾病核心靶点，预测具有防治CMD作用的中药。 方法 使用GeneCards、OMIM数据库获取CMD相关靶点，利用Cytoscape 3.9.1软件中MCODE插件提取子网络，利用cytoNCA插件提取子网络的核心靶点，采用Metascape在线平台对核心靶点进行GO功能及KEGG通路富集分析，利用Coremine Medical数据库进行靶点-中药匹配，对所获得的中药进行筛选，并统计其性味归经及功效分类。 结果 共筛选出CMD相关靶点3 859个，获取5个子网络。提取MCODE1网络核心靶点，共获得IL-1β、IL6、TNF、STAT3、AKT1、ACTB、VEGFA、GAPDH、TP53、ALB 10个核心靶点。GO功能富集分析显示，核心靶点主要涉及基因表达的正向调控、转录的正向调控、DNA模板、基因表达的负调控等生物过程。KEGG通路富集分析获得67条信号通路，主要包括AGEs-RAGE信号通路、HIF-1信号通路、脂肪细胞因子信号通路、流体剪切应力与动脉粥样硬化等。10个核心靶点共关联880味中药，筛选后得到丹参、川芎、红花、赤芍、黄连、人参、麦冬、五味子、肉桂、莲子、蜘蛛香等36味中药。 结论 本研究共预测出36味具有防治CMD作用的中药，为相关中药新药开发提供了研究思路。 Objective To predict Chinese materia medica that may prevent and treat coronary microvascular dysfunction (CMD) by identifying disease core targets. Methods CMD- related targets were obtained through GeneCards and OMIM databases. Subnetworks were extracted by using MCODE plugin in Cytoscape 3.9.1. Core targets of subnetworks were obtained by using cytoNCA plugin. GO function and KEGG pathway enrichment analysis for core targets were performed by using Metascape. Coremine Medical database was used to match targets with Chinese materia medica. Obtained Chinese materia medica was screened, and their properties and tastes, meridians and efficacy categories were under statistics. Results Totally 3 859 disease-related targets were screened and five subnetworks were obtained. An in-depth study of MCODE1 yielded ten core targets, including IL-1β, IL6, TNF, STAT3, AKT1, ACTB, VEGFA, GAPDH, TP53, and ALB. GO functional enrichment analysis showed that these core targets were mainly involved in biological processes, such as positive regulation of gene expression, positive regulation of transcription, DNA template, and negative regulation of gene expression. KEGG pathway enrichment analysis identified 67 signaling pathways, including the AGEs-RAGE signaling pathway, HIF-1 signaling pathway, adipocytokine signaling pathway, fluid shear stress, and atherosclerosis. The researchers identified 36 kinds of Chinese materia medica associated with the ten core targets, including Salviea Miltiorrhizae Radix et Rhizoma, Chuanxiaong Rhizoma, Carthami Flos, Paeoniae Radix Rubra, Coptidis Rhizoma, Ginseng Radix et Rhizoma, Ophiopogonis Radix, Schisandrae Chinensis Fructus, Cinnamomi Cortex, Nelumbinis Semen, and Valerianae Jatamansi Rhizoma et Radix among 880 herbs. Conclusion This study predicts 36 kinds of Chinese materia medica that have the effect of preventing and treating CMD, which can provide research ideas for the development of new drugs.

    冠状动脉疾病微循环疾病核心靶点防治中药

      原文链接:
    • 万方数据

    基于数据挖掘探讨中医药治疗稳定型心绞痛证治规律

    李亨达史攀博薛宁陈亚南...
    229-236页
    查看更多>>摘要：目的 利用数据挖掘技术总结中医药辨证治疗稳定型心绞痛（SAP）的组方思路及配伍规律。 方法 检索中国知识资源总库（CNKI）、中国学术期刊数据库（万方数据）、中文科技期刊数据库（重庆维普）、中国生物医学文献服务系统（SinoMed）建库至2022年2月28日有关中医药治疗SAP的临床研究文献，采用Clementine 12.0、Excel 2016、SPSS Statistics 22.0软件对中药数据进行频次统计、聚类分析及关联规则分析，总结核心处方。 结果 纳入处方289首，涉及中药185味，包含中医证型38种。基于SAP“病”的整体研究发现，临床治疗SAP以活血化瘀药、补虚扶正药、理气化痰药为主，使用频次较高的中药包括川芎、丹参、甘草、黄芪、当归等；常用药对包括川芎-当归、川芎-红花、川芎-枳实等。药物复杂网络图及聚类分析显示，补阳还五汤化裁方是治疗SAP的基本方；基于SAP“证”的研究发现，气虚血瘀证、痰瘀互结证、气滞血瘀证是SAP较为常见的中医证型，三者用药均以温、平为主；药味均以甘、辛、苦为主，多归肝、脾、肺、心经。其中，气虚血瘀证以黄芪、川芎、丹参等高频药物组成的补阳还五汤为基本方；痰瘀互结证常以制半夏、川芎、薤白等高频药物组成的瓜蒌薤白半夏汤合桃红四物汤为基本方；气滞血瘀证以川芎、当归、枳壳等高频药物组成的血府逐瘀汤为基本方。药物聚类分析气虚血瘀证与气滞血瘀证可分为3类，痰瘀互结证可分为4类。 结论 虚、瘀、痰、滞是SAP的重要病理因素，其中气虚为发病基础，血瘀贯穿本病始终，或兼痰浊及气滞之证。围绕着本虚标实的病机，临床多治以补虚药和活血化瘀药，辨证选方。 Objective To summarize the thinking and compatibility law of TCM in the treatment of stable angina pectoris (SAP) based on syndrome differentiation using data mining technology. Methods The clinical studies of TCM treatment for SAP in databases of CNKI, Wanfang Data, VIP and SinoMed China Biomedical Literature Service System were retrieved from the establishment of the databases to February 28, 2022. The frequency statistic, clustering analysis and association rule analysis of TCM data were conducted using Clementine 12.0, Excel 2016, SPSS Statistics 22.0 software, and core prescriptions were summarized. Results Totally 289 prescriptions were included, involving 185 kinds of Chinese materia medica, including 38 TCM syndrome types. Based on the overall study of SAP "disease", the clinical treatment of SAP was mainly based on the drugs for activating blood circulation and removing blood stasis, tonifying deficiency and strengthening healthy qi, and regulating qi and resolving phlegm. The single Chinese materia medica with high frequency of use were Chuanxiaong Rhizoma, Salviea Miltiorrhizae Radix et Rhizoma, Glycyrrhizae Radix et Rhizoma, Angelicae Sinensis Radix, Angelicae Sinensis Radix, etc. The commonly used drug pairs included Chuanxiaong Rhizoma-Angelicae Sinensis Radix, Chuanxiaong Rhizoma-Carthami Flos, Chuanxiaong Rhizoma-Aurantii Fructus Immaturus, etc. The drug complex network diagram and clustering analysis showed that the prescription of Buyang Huanwu Decoction was the basic prescription for the treatment of SAP based on the specific research of SAP "syndrome", the most common TCM syndromes of SAP were qi deficiency and blood stasis, phlegm and blood stasis, and qi stagnation and blood stasis. The drug properties of the three drugs were mainly warm and mild the tastes were mainly sweet, pungent and bitter, and most of them belong to the liver, spleen, lung and heart meridian in terms of specific medication, the basic prescription of qi deficiency and blood stasis syndrome was Buyang Huanwu Decoction, which was composed of high-frequency drugs such as Angelicae Sinensis Radix, Chuanxiaong Rhizoma, Salviea Miltiorrhizae Radix et Rhizoma, etc The phlegm and blood stasis syndrome was often based on the Gualou Xiebai Banxia Decoction and Taohong Siwu Decoction, which were composed of high frequency drugs such as Pinelliae Rhizoma, Chuanxiaong Rhizoma, Allii Macrostemonis Bulbus, etc the basic prescription of qi stagnation and blood stasis syndrome was Xuefu Zhuyu Decoction, which was composed of high frequency drugs such as Chuanxiaong Rhizoma, Angelicae Sinensis Radix, Aurantii Fructus. Drug clustering analysis showed that both qi deficiency and blood stasis syndrome and qi stagnation and blood stasis syndrome were divided into 3 categories, and phlegm and blood stasis syndrome were divided into 4 categories. Conclusions Deficiency, blood stasis, phlegm and stagnation are important pathological factors of SAP, in which qi deficiency is the basis of SAP, blood stasis runs through the disease, or both phlegm and qi stagnation. Focusing on the pathogenesis of deficiency in root and excess in superficiality, drugs with the efficacy of tonifying the deficiency and promoting blood circulation and removing blood stasis are used in clinical treatment, according to different syndrome differentiation of prescription selection.

    心绞痛,稳定型数据挖掘中医药病证结合用药规律

      原文链接:
    • 万方数据

    基于数据挖掘探讨中医药治疗血栓性浅静脉炎用药规律

    王唱曹建春常金霞常久...
    237-242页
    查看更多>>摘要：目的 通过数据挖掘方法探讨中药治疗血栓性浅静脉炎（SVT）的用药规律。 方法 检索中国知识资源总库（CNKI）、中国学术期刊数据库（万方数据）、中文科技期刊数据库（重庆维普）建库至2022年11月27日有关中医药治疗SVT的文献，采用WPS表格 12.1.0.15990对中药频次及其性味归经分布进行统计分析，分别采用SPSS Modeler 18.0、SPSS Statistics 25.0软件，对高频用药进行关联规则分析及聚类分析，总结中医药治疗SVT的用药规律。 结果 纳入文献281篇，包括内服方245首，涉及中药182味；外用方123首，涉及中药188味。其中，内服中药的高频用药有当归、赤芍、牛膝等，外用中药的高频用药有大黄、黄柏、红花等，均以清热药和活血化瘀药为主。高频内服中药药性多为微寒、平、寒性，药味以苦、甘味居多，归经以肝、心、脾、肺经为主；高频外用中药药性多为寒、温性，药味以苦、辛味为主，归经以肝、心、脾、胃经为主。内服中药关联规则有22条，外用中药关联规则有7条。聚类分析中，内服中药可分为5类，外用药可分为4类。 结论 中医药治疗SVT以清热、活血化瘀为基本治法，随证搭配，体现了中医的整体观念和辨证论治。 Objective To explore the medication law of TCM in the treatment of superficial vein thrombosis (SVT) using data mining. Methods Literature about TCM in the treatment of SVT was retrieved from CNKI, Wanfang Data, and VIP from the establishment of the databases to November 27th, 2022. WPS 12.1.0.15990 was used to conduct statistical analysis on drug frequency, property and taste and meridian. The association rules and systematic clustering were carried out by SPSS Modeler 18.0 and SPSS Statistics 25.0. Finally the medication law of TCM in the treatment of SVT was summarized and refined. Results A total of 281 articles were included, including 245 internal prescriptions with 182 kinds of Chinese materia medica, and 123 external prescriptions with 188 kinds of Chinese materia medica. The high frequency used oral Chinese materia medica were mainly Angelicae Sinensis Radix, Paeoniae Radix Rubra, Cyathulae Radix, while the high frequency drugs used externally mainly included Rhei Radix et Rhizoma, Phellodendri Chinensis Cortex, Carthami Flos. These Chinese materia medica were mainly heat-clearing and blood-stasis activators drugs. The medicinal properties of high frequency oral Chinese materia medica were mainly slightly cold, flat and cold,and the tastes were mainly bitter and sweet, and the meridian were mainly liver, heart, spleen and lung. The medicinal properties of high-frequency external Chinese materia medica were mainly cold and warm, and the tastes were mainly bitter and pungent, and the meridian were mainly liver, heart, spleen and stomach. There were 22 rules of association for internal TCM and 7 for external use. The clustering analysis divided oral drugs into 5 categories and topical drugs into 4 categories. Conclusion TCM treatment of SVT is based on clearing heat, activating blood circulation and resolving blood stasis, and matching with the syndromes, which reflects the holistic concept of TCM and the perspective of syndrome differentiation and treatment.

    血栓性静脉炎青蛇毒中医药数据挖掘用药规律

      原文链接:
    • 万方数据

    基于数据挖掘探讨大椎临床应用规律

    姚雅淇张翔徐寅翔熊淑馨...
    243-248页
    查看更多>>摘要：目的 基于数据挖掘探讨大椎主治优势病症与配伍规律。 方法 检索2012年1月1日－2022年8月15日中国知识资源总库（CNKI）、中国学术期刊数据库（万方数据）、中文科技期刊数据库（重庆维普）、中国生物医学文献数据库（CBM）和PubＭed发表的大椎相关文献，归纳其主治病症和腧穴配伍，采用Gephi 0.9.5软件进行复杂网络分析，对比大椎单穴和配伍主治优势病症；采用SPSS Modeler 18.0软件，基于Apriori算法对腧穴组合进行关联规则分析；采用SPSS Statistics 26.0软件对高频腧穴进行聚类分析。 结果 纳入文献722篇，涉及处方732首，单穴主治优势病症为颈椎病、痤疮、和感冒；配伍主治优势病症为颈椎病、变应性鼻炎、缺血性卒中后遗症等14类；经脉配伍以足太阳膀胱经为首，阳经频次高于阴经；腧穴配伍以下合穴、背俞穴、八会穴等特定穴为主，高频腧穴有肺俞、百会、风池、足三里等33个穴，得到4系8类大椎配伍组合。 结论 大椎广泛应用于内科病症，长于呼吸系统疾病、神经系统疾病及椎动脉型颈椎病，倾向于特定穴多重配伍与聚类组合灵活运用。 Objective To discuss dominant symptoms and compatibility rules of Dazhui(GV14) based on data mining. Methods Literature related to Dazhui (GV14) was retrieved from CNKI, Wangfang, VIP, China Biomedical Literature Database (CBM) and Pubmed databases from January 1, 2012 to August 15, 2022, and the main symptoms of Dazhi (GV14) and the compatibility of acupoints were summarized. Gephi 0.9.5 software was used for complex network analysis to compare the treatment for dominant symptoms with single acupoint of Dazhi (GV14) and the compatibility of the acupoint. SPSS Modeler 18.0 software was used to analyze the association rules of acupoint combination based on Apriori algorithm. The clustering analysis of high frequency acupoints was carried out by SPSS Statistics 26.0 software. Results A total of 722 articles were included, involving 732 prescriptions. The dominant symptoms of single acupoint were cervical spondylosis, acne, and cold the treatment for dominant symptoms with compatibility included 14 types, such as cervical spondylosis, allergic rhinitis, ischemic stroke sequelae. The meridian compatibility was dominated by bladder meridian, and the frequency of yang meridians was higher than yin meridians. The compatibility of specific acupoints such as Xiahe acupoint, Beishu acupoint and Bahui acupoint were the main acupoints, and the high frequency acupoints were 33 acupoints such as Feishu (BL13), Baihui (GV20), Fengchi (GB20) and Zusanli (ST36), obtaining 4 series and 8 types of compatible combinations of Dazhui (GV14). Conclusions Dazhui (GV14) is widely used in the treatment of internal diseases, such as respiratory diseases, nervous system diseases and vertebral artery type of cervical spondylosis. It tends to be flexibly used with multiple compatibility and clustering combination of specific acupoints.

    大椎数据挖掘主治病症腧穴配伍文献研究

      原文链接:
    • 万方数据

    基于rbcL序列的辽宁省苍术药材DNA条形码研究

    于莹赵容高铭泽薛嘉宁...
    249-253页
    查看更多>>摘要：目的 采用rbcL序列对辽宁采集北苍术根茎进行鉴定，为保证辽宁省道地药材栽培可行性提供依据。 方法 收集辽宁省10个地区栽培的北苍术根茎共30份，提取总DNA，采用PCR筛选DNA条形码，并对样本的rbcL序列进行扩增、测序，计算扩增成功率和测序成功率；使用MEGA 7.0软件进行序列比对；使用邻接法（NJ）构建系统聚类树。 结果 北苍术根茎DNA提取成功率均为93.3%，PCR扩增和测序成功率均为100%。辽宁省30个北苍术样本中，2个样本存在种内变异，其余北苍术的碱基序列均完全相同。北苍术与菊科近缘种苍术属药材距离较近，与菊科其他属植物之间遗传距离较远。NJ树可区分北苍术及其近缘种药材。 结论 辽宁省北苍术栽培品质量基本相似，rbcL序列可作为北苍术DNA条形码鉴定的有效序列片段。 Objective To use rbcL sequences to identify the rhizomes of the Liaoning collection of Atractylodes chinensis (DC.) Koidz. To provide a basis for ensuring the feasibility of cultivation of the native herb in Liaoning Province. Methods A total of 30 rhizomes of Atractylodes chinensis (DC.) Koidz. were collected from 10 regions cultivated in Liaoning Province, and the total DNA was extracted. DNA barcodes were screened by PCR, and the rbcL sequences of the samples were amplified and sequenced, and the amplification and sequencing success rates were calculated. Sequence alignment was performed using MEGA 7.0 software a systematic clustering tree was constructed using the neighbour-joining method. Results The success rates of DNA extraction from the rhizomes of Atractylodes chinensis (DC.) Koidz. were all 93.3%, and the success rates of PCR amplification and sequencing were all 100%. Among the 30 samples of Atractylodes chinensis (DC.) Koidz. in Liaoning Province, two samples had intraspecific variation, and the rest of the base sequences of Atractylodes chinensis (DC.) Koidz. were identical. Atractylodes chinensis (DC.) Koidz. was closer to the herbs of the genus Cangzhu, a relative species of Asteraceae, and was genetically more distant from the rest of Asteraceae. The NJ tree could distinguish Atractylodes chinensis (DC.) Koidz. and its relatives. Conclusion The quality of Atractylodes chinensis (DC.) Koidz. cultivars in Liaoning Province is basically similar, and the rbcL sequence can be used as a valid sequence fragment for the identification of Atractylodes chinensis (DC.) Koidz. DNA barcode.

    中药鉴定北苍术DNA条形码,分类学rbcL序列药用植物栽培

      原文链接:
    • 万方数据